aluates Reports

$ 0.0

Automative

Global Targeted Drugs for Multiple Sclerosis Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-35I17833

BUY CHAPTERS

Global Targeted Drugs for Multiple Sclerosis Market Research Report 2024

Code: QYRE-Auto-35I17833

Report

August 2024

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

Biogen

Biogen Inc

Novartis

Bristol–Myers Squibb

Janssen

Sanofi

Roche

Targeted Drugs for Multiple Sclerosis Market

The global Targeted Drugs for Multiple Sclerosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Targeted Drugs for Multiple Sclerosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Targeted Drugs for Multiple Sclerosis is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Targeted Drugs for Multiple Sclerosis in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Targeted Drugs for Multiple Sclerosis include Biogen, NOVARTIS, Bristol-Myers Squibb, Janssen, Sanofi, Roche, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Targeted Drugs for Multiple Sclerosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Drugs for Multiple Sclerosis.

The Targeted Drugs for Multiple Sclerosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted Drugs for Multiple Sclerosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Targeted Drugs for Multiple Sclerosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Targeted Drugs for Multiple Sclerosis Market Report

Report Metric	Details
Report Name	Targeted Drugs for Multiple Sclerosis Market
Segment by Type	Injection Oral
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, NOVARTIS, Bristol-Myers Squibb, Janssen, Sanofi, Roche
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Drugs for Multiple Sclerosis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Targeted Drugs for Multiple Sclerosis Market report?

Ans: The main players in the Targeted Drugs for Multiple Sclerosis Market are Biogen, NOVARTIS, Bristol-Myers Squibb, Janssen, Sanofi, Roche

What are the Application segmentation covered in the Targeted Drugs for Multiple Sclerosis Market report?

Ans: The Applications covered in the Targeted Drugs for Multiple Sclerosis Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Targeted Drugs for Multiple Sclerosis Market report?

Ans: The Types covered in the Targeted Drugs for Multiple Sclerosis Market report are Injection, Oral

Recommended Reports

Neurodegenerative Diseases

Targeted Drug Markets

CNS & Autoimmune Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Targeted Drugs for Multiple Sclerosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Injection

1.2.3 Oral

1.3 Market by Application

1.3.1 Global Targeted Drugs for Multiple Sclerosis Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Targeted Drugs for Multiple Sclerosis Market Perspective (2019-2030)

2.2 Global Targeted Drugs for Multiple Sclerosis Growth Trends by Region

2.2.1 Global Targeted Drugs for Multiple Sclerosis Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Targeted Drugs for Multiple Sclerosis Historic Market Size by Region (2019-2024)

2.2.3 Targeted Drugs for Multiple Sclerosis Forecasted Market Size by Region (2025-2030)

2.3 Targeted Drugs for Multiple Sclerosis Market Dynamics

2.3.1 Targeted Drugs for Multiple Sclerosis Industry Trends

2.3.2 Targeted Drugs for Multiple Sclerosis Market Drivers

2.3.3 Targeted Drugs for Multiple Sclerosis Market Challenges

2.3.4 Targeted Drugs for Multiple Sclerosis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Targeted Drugs for Multiple Sclerosis Players by Revenue

3.1.1 Global Top Targeted Drugs for Multiple Sclerosis Players by Revenue (2019-2024)

3.1.2 Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Players (2019-2024)

3.2 Global Targeted Drugs for Multiple Sclerosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Targeted Drugs for Multiple Sclerosis Revenue

3.4 Global Targeted Drugs for Multiple Sclerosis Market Concentration Ratio

3.4.1 Global Targeted Drugs for Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Targeted Drugs for Multiple Sclerosis Revenue in 2023

3.5 Global Key Players of Targeted Drugs for Multiple Sclerosis Head office and Area Served

3.6 Global Key Players of Targeted Drugs for Multiple Sclerosis, Product and Application

3.7 Global Key Players of Targeted Drugs for Multiple Sclerosis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Targeted Drugs for Multiple Sclerosis Breakdown Data by Type

4.1 Global Targeted Drugs for Multiple Sclerosis Historic Market Size by Type (2019-2024)

4.2 Global Targeted Drugs for Multiple Sclerosis Forecasted Market Size by Type (2025-2030)

5 Targeted Drugs for Multiple Sclerosis Breakdown Data by Application

5.1 Global Targeted Drugs for Multiple Sclerosis Historic Market Size by Application (2019-2024)

5.2 Global Targeted Drugs for Multiple Sclerosis Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Targeted Drugs for Multiple Sclerosis Market Size (2019-2030)

6.2 North America Targeted Drugs for Multiple Sclerosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Targeted Drugs for Multiple Sclerosis Market Size by Country (2019-2024)

6.4 North America Targeted Drugs for Multiple Sclerosis Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Targeted Drugs for Multiple Sclerosis Market Size (2019-2030)

7.2 Europe Targeted Drugs for Multiple Sclerosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Targeted Drugs for Multiple Sclerosis Market Size by Country (2019-2024)

7.4 Europe Targeted Drugs for Multiple Sclerosis Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Size (2019-2030)

8.2 Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Size by Region (2019-2024)

8.4 Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Targeted Drugs for Multiple Sclerosis Market Size (2019-2030)

9.2 Latin America Targeted Drugs for Multiple Sclerosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Targeted Drugs for Multiple Sclerosis Market Size by Country (2019-2024)

9.4 Latin America Targeted Drugs for Multiple Sclerosis Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size (2019-2030)

10.2 Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Country (2019-2024)

10.4 Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Targeted Drugs for Multiple Sclerosis Introduction

11.1.4 Biogen Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

11.1.5 Biogen Recent Development

11.2 NOVARTIS

11.2.1 NOVARTIS Company Details

11.2.2 NOVARTIS Business Overview

11.2.3 NOVARTIS Targeted Drugs for Multiple Sclerosis Introduction

11.2.4 NOVARTIS Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

11.2.5 NOVARTIS Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Targeted Drugs for Multiple Sclerosis Introduction

11.3.4 Bristol-Myers Squibb Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Janssen

11.4.1 Janssen Company Details

11.4.2 Janssen Business Overview

11.4.3 Janssen Targeted Drugs for Multiple Sclerosis Introduction

11.4.4 Janssen Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

11.4.5 Janssen Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Targeted Drugs for Multiple Sclerosis Introduction

11.5.4 Sanofi Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

11.5.5 Sanofi Recent Development

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Targeted Drugs for Multiple Sclerosis Introduction

11.6.4 Roche Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

11.6.5 Roche Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

Biogen

Biogen Inc

Novartis

Bristol–Myers Squibb

Janssen

Sanofi

Roche

List of Tables

Table 1. Global Targeted Drugs for Multiple Sclerosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Injection

Table 3. Key Players of Oral

Table 4. Global Targeted Drugs for Multiple Sclerosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Targeted Drugs for Multiple Sclerosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Targeted Drugs for Multiple Sclerosis Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Targeted Drugs for Multiple Sclerosis Market Share by Region (2019-2024)

Table 8. Global Targeted Drugs for Multiple Sclerosis Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Targeted Drugs for Multiple Sclerosis Market Share by Region (2025-2030)

Table 10. Targeted Drugs for Multiple Sclerosis Market Trends

Table 11. Targeted Drugs for Multiple Sclerosis Market Drivers

Table 12. Targeted Drugs for Multiple Sclerosis Market Challenges

Table 13. Targeted Drugs for Multiple Sclerosis Market Restraints

Table 14. Global Targeted Drugs for Multiple Sclerosis Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Targeted Drugs for Multiple Sclerosis Market Share by Players (2019-2024)

Table 16. Global Top Targeted Drugs for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Multiple Sclerosis as of 2023)

Table 17. Ranking of Global Top Targeted Drugs for Multiple Sclerosis Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Targeted Drugs for Multiple Sclerosis Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Targeted Drugs for Multiple Sclerosis, Headquarters and Area Served

Table 20. Global Key Players of Targeted Drugs for Multiple Sclerosis, Product and Application

Table 21. Global Key Players of Targeted Drugs for Multiple Sclerosis, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Targeted Drugs for Multiple Sclerosis Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Type (2019-2024)

Table 25. Global Targeted Drugs for Multiple Sclerosis Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Type (2025-2030)

Table 27. Global Targeted Drugs for Multiple Sclerosis Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Application (2019-2024)

Table 29. Global Targeted Drugs for Multiple Sclerosis Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Targeted Drugs for Multiple Sclerosis Revenue Market Share by Application (2025-2030)

Table 31. North America Targeted Drugs for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Targeted Drugs for Multiple Sclerosis Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Targeted Drugs for Multiple Sclerosis Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Targeted Drugs for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Targeted Drugs for Multiple Sclerosis Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Targeted Drugs for Multiple Sclerosis Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Targeted Drugs for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Targeted Drugs for Multiple Sclerosis Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Targeted Drugs for Multiple Sclerosis Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size by Country (2025-2030) & (US$ Million)

Table 46. Biogen Company Details

Table 47. Biogen Business Overview

Table 48. Biogen Targeted Drugs for Multiple Sclerosis Product

Table 49. Biogen Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024) & (US$ Million)

Table 50. Biogen Recent Development

Table 51. NOVARTIS Company Details

Table 52. NOVARTIS Business Overview

Table 53. NOVARTIS Targeted Drugs for Multiple Sclerosis Product

Table 54. NOVARTIS Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024) & (US$ Million)

Table 55. NOVARTIS Recent Development

Table 56. Bristol-Myers Squibb Company Details

Table 57. Bristol-Myers Squibb Business Overview

Table 58. Bristol-Myers Squibb Targeted Drugs for Multiple Sclerosis Product

Table 59. Bristol-Myers Squibb Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024) & (US$ Million)

Table 60. Bristol-Myers Squibb Recent Development

Table 61. Janssen Company Details

Table 62. Janssen Business Overview

Table 63. Janssen Targeted Drugs for Multiple Sclerosis Product

Table 64. Janssen Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024) & (US$ Million)

Table 65. Janssen Recent Development

Table 66. Sanofi Company Details

Table 67. Sanofi Business Overview

Table 68. Sanofi Targeted Drugs for Multiple Sclerosis Product

Table 69. Sanofi Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. Roche Company Details

Table 72. Roche Business Overview

Table 73. Roche Targeted Drugs for Multiple Sclerosis Product

Table 74. Roche Revenue in Targeted Drugs for Multiple Sclerosis Business (2019-2024) & (US$ Million)

Table 75. Roche Recent Development

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

Table 79. Authors List of This Report

List of Figures

Figure 1. Targeted Drugs for Multiple Sclerosis Picture

Figure 2. Global Targeted Drugs for Multiple Sclerosis Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Targeted Drugs for Multiple Sclerosis Market Share by Type: 2023 VS 2030

Figure 4. Injection Features

Figure 5. Oral Features

Figure 6. Global Targeted Drugs for Multiple Sclerosis Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Targeted Drugs for Multiple Sclerosis Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Other Case Studies

Figure 11. Targeted Drugs for Multiple Sclerosis Report Years Considered

Figure 12. Global Targeted Drugs for Multiple Sclerosis Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Targeted Drugs for Multiple Sclerosis Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Targeted Drugs for Multiple Sclerosis Market Share by Region: 2023 VS 2030

Figure 15. Global Targeted Drugs for Multiple Sclerosis Market Share by Players in 2023

Figure 16. Global Top Targeted Drugs for Multiple Sclerosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Drugs for Multiple Sclerosis as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Targeted Drugs for Multiple Sclerosis Revenue in 2023

Figure 18. North America Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Targeted Drugs for Multiple Sclerosis Market Share by Country (2019-2030)

Figure 20. United States Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Targeted Drugs for Multiple Sclerosis Market Share by Country (2019-2030)

Figure 24. Germany Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Targeted Drugs for Multiple Sclerosis Market Share by Region (2019-2030)

Figure 32. China Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Targeted Drugs for Multiple Sclerosis Market Share by Country (2019-2030)

Figure 40. Mexico Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Targeted Drugs for Multiple Sclerosis Market Share by Country (2019-2030)

Figure 44. Turkey Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Targeted Drugs for Multiple Sclerosis Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Biogen Revenue Growth Rate in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

Figure 48. NOVARTIS Revenue Growth Rate in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

Figure 50. Janssen Revenue Growth Rate in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

Figure 51. Sanofi Revenue Growth Rate in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

Figure 52. Roche Revenue Growth Rate in Targeted Drugs for Multiple Sclerosis Business (2019-2024)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

Figure 55. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Targeted Drugs for Alzheimer s Disease Market Research Report 2024

Global Targeted Drugs for Neurodegenerative Diseases Market Research Report 2024

Global Targeted Drugs for Parkinson s Disease Market Research Report 2024

Multiple Sclerosis Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Delivery Drugs Market Research Report 2024

Global Multiple Sclerosis Drugs Treatment Market Insights Forecast to 2030

Global Targeted Drugs for Huntington s Disease Market Research Report 2024

Relapsing Multiple Sclerosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Systemic Sclerosis Drug Market Research Report 2025

Global Targeted Drugs for Multiple Myeloma Market Research Report 2024

Targeted Radionuclide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drugs for Breast Cancer Market Research Report 2024

Global Targeted Drugs for NSCLC Market Research Report 2024

Global Soft Tissue Sarcoma Targeted Drugs Market Research Report 2024

Global Scleroderma Treatment Market Research Report 2025

Global Small Molecule Targeted Therapy Market Insights Forecast to 2030

Scleroderma Diagnostics and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Protein Degradation Drug Market Research Report 2024

Global Specialty Pharmaceuticals Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions